DrugPatentWatch Database Preview
Somerset Company Profile
» See Plans and Pricing
What is the competitive landscape for SOMERSET, and what generic and branded alternatives to SOMERSET drugs are available?
SOMERSET has thirty-two approved drugs.
Summary for Somerset
| US Patents: | 0 |
| Tradenames: | 28 |
| Ingredients: | 25 |
| NDAs: | 32 |
Drugs and US Patents for Somerset
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Somerset Theraps Llc | GLYCOPYRROLATE | glycopyrrolate | INJECTABLE;INJECTION | 207639-001 | Jun 23, 2017 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Somerset | VERAPAMIL HYDROCHLORIDE | verapamil hydrochloride | SOLUTION;INTRAVENOUS | 211035-002 | Jun 18, 2018 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Somerset Theraps Llc | PILOCARPINE HYDROCHLORIDE | pilocarpine hydrochloride | SOLUTION;OPHTHALMIC | 210384-003 | Nov 25, 2019 | AT | RX | No | No | Start Trial | Start Trial | ||||
| Somerset Theraps Llc | VERAPAMIL HYDROCHLORIDE | verapamil hydrochloride | SOLUTION;INTRAVENOUS | 211015-002 | Jun 18, 2018 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Somerset Theraps Llc | DEXAMETHASONE SODIUM PHOSPHATE | dexamethasone sodium phosphate | INJECTABLE;INJECTION | 211036-001 | May 10, 2019 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Somerset Theraps Llc | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | SOLUTION;INJECTION | 207636-006 | Jun 15, 2018 | AP | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Somerset
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Somerset | EMSAM | selegiline | FILM, EXTENDED RELEASE;TRANSDERMAL | 021336-003 | Feb 27, 2006 | 7,070,808 | Start Trial |
| Somerset | EMSAM | selegiline | FILM, EXTENDED RELEASE;TRANSDERMAL | 021336-001 | Feb 27, 2006 | 7,070,808 | Start Trial |
| Somerset | EMSAM | selegiline | FILM, EXTENDED RELEASE;TRANSDERMAL | 021336-002 | Feb 27, 2006 | 7,070,808 | Start Trial |
| Somerset | EMSAM | selegiline | FILM, EXTENDED RELEASE;TRANSDERMAL | 021336-003 | Feb 27, 2006 | 7,638,140 | Start Trial |
| Somerset | EMSAM | selegiline | FILM, EXTENDED RELEASE;TRANSDERMAL | 021336-002 | Feb 27, 2006 | RE34579 | Start Trial |
| Somerset | EMSAM | selegiline | FILM, EXTENDED RELEASE;TRANSDERMAL | 021336-002 | Feb 27, 2006 | 7,150,881 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
